BCL2 and lymphoma: Among the non-Ig partners is BCL6; in one study, the majority of lymphomas with rearrangements of MYC, BCL2 and BCL6 (“triple-hit” lymphomas) harbored BCL6::MYC rearrangements,(36) suggesting that such cases may be considered pseudo-triple hit lymphomas.